HIGHLIGHT
Salofalk

Salofalk Description

mesalazine

Manufacturer:

Falk

Distributor:

DCH Auriga
Full Prescribing Info
Description
Each sachet of Salofalk 1.5g granules contains 1.5 g mesalazine.
Excipients/Inactive Ingredients: Each tablet also contains the following excipients: Sodium carbonate, eudragit L/dibutylphthalate, talcum, poly(vinyl-2-pyrrolidone), microcrystalline cellulose, carboxymethylcellulose sodium, glycine, calcium stearate, silica, hydroxypropylmethylcellulose, eudragit E, macrogol 6000, titanium dioxide (E171), yellow iron oxide (E172).
Each sachet of Salofalk 1.5g granules contains 3.0 mg aspartame.
Granules: Aspartame (E 951); Carmellose sodium; Citric acid; Colloidal anhydrous silica; Hypromellose; Magnesium stearate; Methacrylic acid-methyl methacrylate copolymer (1:1) ((MW approx. 135000)) (Eudragit L 100); Methylcellulose; Microcrystalline Cellulose; Polyacrylate dispersion 40 % (Eudragit NE 40 D containing 2 % Nonoxynol 100); Povidone K 25; Simeticone; Sorbic acid; Talc; Titanium dioxide (E 171); Triethyl citrate; Vanilla custard flavouring; Ethanol (only present as residue in the final product, up to 1.25 %).
Each suppository also contains the following excipients: Hard fat, docusate sodium and cetyl alcohol.
The enema also contains the following excipients: Sodium benzoate (0.03 g), potassium metabisulfite (max. 0.14 g), disodium edetate, carbomer, potassium acetate, xanthan gum.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in